Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab

Aman Sharma, Susheel Kumar, Ajay Wanchu, Vivek Lal, Ramandeep Singh, Vishali Gupta, Surjit Singh, Amod Gupta

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Central nervous involvement (CNS) is uncommon manifestation of Wegener's granulomatosis (WG). We are describing a patient with refractory WG with CNS involvement which responded to rituximab. This lady presented with nodular scleritis. Three months later, she developed headache, vision loss with complete opthalmoplegia, and relative afferent papillary defect. The brain MRI showed thickened dura along ant temporal region and enlargement of right cavernous sinus. C ANCA and PR 3 ELISA were positive. Non-contrast CT scan of orbit and paranasal sinuses showed soft tissue swelling of the right orbit along with mucosal thickening of right maxillary sinus. There were bilateral upper lobe nodules on HRCT of the chest. She responded to 3 days of methylprednisolone pulses and 1 g pulse cyclophosphamide but had multiple relapses while receiving high dose oral steroids and pulse cyclophosphamide. Then she was given four infusions of rituximab (375 mg/m2) at one-weekly interval. She had complete remission following rituximab. She relapsed after 6 months but again responded to repeat rituximab infusion.

Original languageEnglish (US)
Pages (from-to)107-110
Number of pages4
JournalClinical Rheumatology
Volume29
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Granulomatosis with Polyangiitis
Meningitis
Orbit
Cyclophosphamide
Scleritis
Cavernous Sinus
Antineutrophil Cytoplasmic Antibodies
Ants
Maxillary Sinus
Paranasal Sinuses
Methylprednisolone
Temporal Lobe
Therapeutics
Headache
Thorax
Enzyme-Linked Immunosorbent Assay
Steroids
Recurrence
Rituximab
Brain

Keywords

  • Pachymeningitis
  • Refractory
  • Rituximab
  • Wegener's granulomatosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab. / Sharma, Aman; Kumar, Susheel; Wanchu, Ajay; Lal, Vivek; Singh, Ramandeep; Gupta, Vishali; Singh, Surjit; Gupta, Amod.

In: Clinical Rheumatology, Vol. 29, No. 1, 01.2010, p. 107-110.

Research output: Contribution to journalArticle

Sharma, A, Kumar, S, Wanchu, A, Lal, V, Singh, R, Gupta, V, Singh, S & Gupta, A 2010, 'Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab', Clinical Rheumatology, vol. 29, no. 1, pp. 107-110. https://doi.org/10.1007/s10067-009-1291-z
Sharma, Aman ; Kumar, Susheel ; Wanchu, Ajay ; Lal, Vivek ; Singh, Ramandeep ; Gupta, Vishali ; Singh, Surjit ; Gupta, Amod. / Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab. In: Clinical Rheumatology. 2010 ; Vol. 29, No. 1. pp. 107-110.
@article{6455dda6d67242e19cef41dd21f4a677,
title = "Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab",
abstract = "Central nervous involvement (CNS) is uncommon manifestation of Wegener's granulomatosis (WG). We are describing a patient with refractory WG with CNS involvement which responded to rituximab. This lady presented with nodular scleritis. Three months later, she developed headache, vision loss with complete opthalmoplegia, and relative afferent papillary defect. The brain MRI showed thickened dura along ant temporal region and enlargement of right cavernous sinus. C ANCA and PR 3 ELISA were positive. Non-contrast CT scan of orbit and paranasal sinuses showed soft tissue swelling of the right orbit along with mucosal thickening of right maxillary sinus. There were bilateral upper lobe nodules on HRCT of the chest. She responded to 3 days of methylprednisolone pulses and 1 g pulse cyclophosphamide but had multiple relapses while receiving high dose oral steroids and pulse cyclophosphamide. Then she was given four infusions of rituximab (375 mg/m2) at one-weekly interval. She had complete remission following rituximab. She relapsed after 6 months but again responded to repeat rituximab infusion.",
keywords = "Pachymeningitis, Refractory, Rituximab, Wegener's granulomatosis",
author = "Aman Sharma and Susheel Kumar and Ajay Wanchu and Vivek Lal and Ramandeep Singh and Vishali Gupta and Surjit Singh and Amod Gupta",
year = "2010",
month = "1",
doi = "10.1007/s10067-009-1291-z",
language = "English (US)",
volume = "29",
pages = "107--110",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "1",

}

TY - JOUR

T1 - Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab

AU - Sharma, Aman

AU - Kumar, Susheel

AU - Wanchu, Ajay

AU - Lal, Vivek

AU - Singh, Ramandeep

AU - Gupta, Vishali

AU - Singh, Surjit

AU - Gupta, Amod

PY - 2010/1

Y1 - 2010/1

N2 - Central nervous involvement (CNS) is uncommon manifestation of Wegener's granulomatosis (WG). We are describing a patient with refractory WG with CNS involvement which responded to rituximab. This lady presented with nodular scleritis. Three months later, she developed headache, vision loss with complete opthalmoplegia, and relative afferent papillary defect. The brain MRI showed thickened dura along ant temporal region and enlargement of right cavernous sinus. C ANCA and PR 3 ELISA were positive. Non-contrast CT scan of orbit and paranasal sinuses showed soft tissue swelling of the right orbit along with mucosal thickening of right maxillary sinus. There were bilateral upper lobe nodules on HRCT of the chest. She responded to 3 days of methylprednisolone pulses and 1 g pulse cyclophosphamide but had multiple relapses while receiving high dose oral steroids and pulse cyclophosphamide. Then she was given four infusions of rituximab (375 mg/m2) at one-weekly interval. She had complete remission following rituximab. She relapsed after 6 months but again responded to repeat rituximab infusion.

AB - Central nervous involvement (CNS) is uncommon manifestation of Wegener's granulomatosis (WG). We are describing a patient with refractory WG with CNS involvement which responded to rituximab. This lady presented with nodular scleritis. Three months later, she developed headache, vision loss with complete opthalmoplegia, and relative afferent papillary defect. The brain MRI showed thickened dura along ant temporal region and enlargement of right cavernous sinus. C ANCA and PR 3 ELISA were positive. Non-contrast CT scan of orbit and paranasal sinuses showed soft tissue swelling of the right orbit along with mucosal thickening of right maxillary sinus. There were bilateral upper lobe nodules on HRCT of the chest. She responded to 3 days of methylprednisolone pulses and 1 g pulse cyclophosphamide but had multiple relapses while receiving high dose oral steroids and pulse cyclophosphamide. Then she was given four infusions of rituximab (375 mg/m2) at one-weekly interval. She had complete remission following rituximab. She relapsed after 6 months but again responded to repeat rituximab infusion.

KW - Pachymeningitis

KW - Refractory

KW - Rituximab

KW - Wegener's granulomatosis

UR - http://www.scopus.com/inward/record.url?scp=72949117249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949117249&partnerID=8YFLogxK

U2 - 10.1007/s10067-009-1291-z

DO - 10.1007/s10067-009-1291-z

M3 - Article

C2 - 19802640

AN - SCOPUS:72949117249

VL - 29

SP - 107

EP - 110

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 1

ER -